Intomics enters €5.2M personalised cancer diagnostic project

The project will optimize treatment of cancer patients based on the cancers’ individual genetic fingerprint. Intomics will use its leading biomedical data analysis capabilities to help choose the right treatment from cancer-derived genetic information. The project receives €3.0M in financial support from The Danish National Advanced Technology Foundation.Two cancer patients may respond very differently to the same treatment if their genetic cancer fingerprints differ.  Mutations in genes participating in key cancer pathways and mechanisms may impact whether a given patient responds well to a treatment or not.

Press Release Distribution , Intomics enters €5.2M personalised cancer diagnostic project, Intomics enters €5.2M personalised cancer diagnostic project